Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: A prospective, multicenter, open-label, singlearm phase II study

Định dạng: PDF / Số trang: 8

Nhắn tin với admin nếu không tải được